Ventorp F, Bay-Richter C, Nagendra AS, Janelidze S, Matsson VS, Lipton J, et al
It's crucial to consult a qualified healthcare professional to fully understand the risks and current regulatory status before exploring such treatments
TRIUMPH-1 es un ensayo fase 3, multicntrico (13 pases), doble ciego y controlado con placebo, que incluy a 2.339 adultos con obesidad o sobrepeso sin DM2, tratados durante 80 semanas, con una extensin preespecificada hasta las 104 semanas en quienes partan de un IMC 35 kg/m
A few commenters expressed concern that the reduced timeframe encourages hospitals, REHs, or ASCs to divert critical staff at a time they are needed most and would force them to prioritize paperwork over patient care, undermining the goals of the CMS quality reporting and value programs